8/23/2025Recent Executive Moves

8/23/2025IxCell Secures New Financing to Advance Cell Therapy Programs

8/22/2025InxMed Secures Over $34M in Series C Financing to Advance Oncology Pip...

8/22/2025Bao Pharma Advances with Hong Kong IPO amid Promising Pipeline

8/22/2025LongBio Advances with Hong Kong IPO Amidst Promising Clinical Pipeline

8/22/2025NMPA Approves AZ/Daiichi Sankyo’s Datopotamab Deruxtecan

8/22/2025Innovent Advances Immuno-Oncology with IBI3026 CTA Acceptance

8/22/2025Xuanzhu's Dexitinib Gains Approval for ALK-Positive Advanced NSCLC in ...

8/22/2025NMPA Approves Domestic Hexavalent Rotavirus Vaccine for Children

8/22/2025CARsgen's Satri-cel Becomes First CAR-T Therapy for Solid Tumors to Re...

8/22/2025Kintor's KX-826 Tincture Nabs Triumph in Phase II Male AGA Trial

More>>

8/22/2025Premier Li Visits BeOne, Signaling China's Strategic Push for Biotech ...

8/20/2025On the Cusp of a Cure: Is Asia Pacific Ready for the Precision Era? (C...

8/19/2025Six Key Insights Into China Biotech's NewCo Model (Mondaq)

8/19/2025Leaving China Manufacturing: The Hidden Risks And How To Protect Your ...

8/19/2025Adjudication Of Drug Patent Linkage Cases When The Originator Drug's T...

8/19/2025U.S. Tariffs Pressure Mounting, Japanese Pharma Looks East for Growth ...

8/14/2025China Sees Surge in Innovative Drug Approvals in H1, Covering Cancer, ...

8/13/2025The Trends Shaping Chinese Pharma Patent Litigation (Mondaq)

8/8/2025China Biopharma Tracker – July 2025: Funding Surges and Major Deals (...

8/8/2025Pharma MNCs in China H1/2025 – Mature Products Exit, Top Performers R...

8/7/2025Innovation through Talent: How Leadership Is Evolving in China's Life ...

More>>